SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

SELTER ERIC JAY

(Last)

(First)

(Middle)

11726 SAN VICENTE BLVD.

SUITE 650

(Street)

LOS ANGELES

90049

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
04/30/2015

3. Issuer Name and Ticker or Trading Symbol
CYTRX CORP [ CYTR ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
CytRx Common Stock	27,144	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock option (right to buy)⁽¹⁾	04/30/2015	04/29/2025	CytRx common stock	180,000	$4.39	D
Stock option (right to buy)⁽²⁾	07/18/2005	07/17/2015	CytRx Common Stock	1,071	$5.88	D
Stock option (right to buy)	07/18/2006	07/17/2016	CytRx Common Stock	1,786	$7.77	D
Stock option (right to buy)	07/10/2007	07/09/2017	CytRx Common Stock	1,786	$23.31	D
Stock option (right to buy)	07/01/2008	06/30/2018	CytRx Common Stock	1,786	$3.99	D
Stock option (right to buy)	07/01/2009	06/30/2019	CytRx Common Stock	3,571	$8.05	D
Stock option (right to buy)	06/29/2010	06/28/2020	CytRx Common Stock	3,571	$5.46	D
Stock option (right to buy)	06/30/2011	06/29/2021	CytRx Common Stock	3,571	$5.04	D
Stock option (right to buy)	05/14/2012	05/13/2022	CytRx Common Stock	3,571	$2.8	D
Stock option (right to buy)	12/10/2012	12/09/2022	CytRx Common Stock	50,000	$1.83	D
Stock option (right to buy)	12/10/2013	12/09/2023	CytRx Common Stock	90,000	$2.39	D

Explanation of Responses:

1. This option is Mr. Selter's equity compensation upon becoming a director on CytRx's Board of Directors. The exercise price equals the closing price of CytRx common stock on April 30, 2015, the date Mr. Selter was appointed to the Board.

2. Prior to joining the CytRx Board of Directors, Eric Selter was given as a gift by his father, Marvin Selter, who was at the time a director on the Board, options totalling 160,713 shares, which equals half of the amount of options granted to Marvin Selter as his equity compensation for service as a director. The option grants are listed individually by year granted.

Remarks:

	Eric J. Selter	05/04/2015
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.